|Phone||+7 495 545-39-12|
RusnanoMedInvest (RMI) is Russia’s and Eastern Europe’s largest venture capital company specializing in innovative developments in the field of pharmaceuticals and biotechnology.
The RusnanoMedInvest fund was established by RUSNANO JSC, the nanotechnology investment, research and development arm of the Russian Government together with Domain Associates LLC, one of the premier U.S. life sciences technology venture investment firms. The RusnanoMedInvest fund seeks, in addition to securing differentiated and sustainable returns to its investment portfolio, to promote the following social and developmental objectives in Russia.
|Miramar Labs||2/2014||Series D||$10M||5|
|NovaDigm Therapeutics||10/2013||Series B||$14M||2|
|Syndax Pharmaceuticals||8/2013||Series B||$26.6M||4|
|ReVision Optics||7/2013||Private Equity||$55M||6|
|Regado Biosciences||12/2012||Series E||$51M||8|